Our Experts in the News
-
Policy Deciphered: Could FDA inspection backlog lead to approval slowdown?
March 11, 2021
Medical Marketing and Media
-
The Alzheimer's approval maze
March 11, 2021
pharma Manufacturing
-
Pandemic Forces F.D.A. to Sharply Curtail Drug Company Inspections
March 9, 2021
The New York Times
-
Alzheimer's Association Denies Conflict in Aducanumab Support
March 8, 2021
Medscape
-
Some retirement communities lure new residents with promise of Covid-19 vaccines
February 18, 2021
NBC News
-
Janet Woodcock slams calls for FDA 'firewall' amid aducanumab debacle, citing need for collaborative drug development
February 17, 2021
Endpoints News
-
After a controversial Alzheimer’s drug review, FDA’s Woodcock rejects proposal to ‘firewall’ agency review staff
February 16, 2021
STAT
-
Biogen Alzheimer’s Drug Puts FDA’s Judgment in Harsh Spotlight
January 30, 2021
Bloomberg
-
'What he is doing is outrageous': Doctors slam Sen. Ron Johnson over hearing on COVID-19 treatments
November 20, 2020
Milwaukee Journal Sentinel
-
Pfizer's COVID-19 Vax: A Good First Step, Say Experts — But questions remain and some criticize "science by press release"
November 9, 2020
MedPage Today
-
FDA’s own documents reveal agency’s lax, slow, and secretive oversight of clinical research
October 1, 2020
Science
Login
Subscribe